Item Type | Name |
Concept
|
Deoxycytosine Nucleotides
|
Concept
|
Thymine Nucleotides
|
Concept
|
Deoxyadenine Nucleotides
|
Concept
|
Adenine Nucleotides
|
Concept
|
Nucleotides
|
Concept
|
Deoxyguanine Nucleotides
|
Academic Article
|
Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome.
|
Academic Article
|
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
|
Academic Article
|
Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia.
|
Academic Article
|
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
|
Academic Article
|
Biochemical modulation of cytarabine triphosphate by clofarabine.
|
Academic Article
|
Defective molecular timer in the absence of nucleotides leads to inefficient caspase activation.
|
Academic Article
|
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
|
Academic Article
|
Interaction of arabinosyl nucleotides in K562 human leukemia cells.
|
Academic Article
|
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
|
Academic Article
|
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
|
Academic Article
|
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
|
Academic Article
|
Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment.
|
Academic Article
|
Clofarabine: past, present, and future.
|
Academic Article
|
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.
|
Academic Article
|
Yet another nucleoside analog for pancreatic cancer.
|
Academic Article
|
Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia.
|
Academic Article
|
Metabolism and action of 2',2'-difluorodeoxycytidine: self-potentiation of cytotoxicity.
|
Academic Article
|
Separation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
|
Academic Article
|
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
|
Academic Article
|
Clofarabine and nelarabine: two new purine nucleoside analogs.
|
Academic Article
|
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
|
Academic Article
|
RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells.
|
Academic Article
|
Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.
|
Academic Article
|
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
|
Academic Article
|
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
|
Academic Article
|
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
|
Academic Article
|
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
|
Academic Article
|
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).
|
Academic Article
|
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia.
|
Academic Article
|
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
|
Academic Article
|
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
|
Academic Article
|
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.
|
Academic Article
|
2',2'-difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells
|
Academic Article
|
Gemcitabine
|
Academic Article
|
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
|
Academic Article
|
The role of p53 and p21 on 8-chloro-adenosine-induced cellular response.
|
Academic Article
|
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia.
|